The Effect of Recombinant Vascular Endothelial Growth Factor (VEGF)-121 Towards Placenta Growth Factor Serum Levels in Female Mice (Mus Musculus) with Preeclampsia Model
Abstract
Background: Preeclampsia is a multi syste
References
Ananth K, Bdolah Y, et al. (2004). Angiogenic Imbalance in the Pathophysiology of Preeclampsia: Newer Insights. Semin Nephrol. 24: 548
Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, Bujold E, Gon
Chen and Novel (2009).Angiogenic Factors for Predicting Preeclampsia: sFlt-1, PlGF, and Soluble Endoglin. Clinical Chemistry Journal. 2: 1-6.
Comiskey M, Warner C, Schust D (2006). MHC molecules of the preimplantation embryo and trophoblast. Immunology of pregnancy. 16:130-142. https://www.ncbi.nlm.nih.gov/books/NBK6277/.
Creasy R (2014). Maternal Fetal Medicine, Principle and Practice.7:756.
Cuningham (2013). William Obstetric. Twenty fifth Edition. MD: Lippincot Williams; Wilkins. 762-763.
Gilbert J., et al. (2010). Recombinant Vascular Endothelial Growth Factor 121 Infusion Lowers Blood Pressure and Improves Renal Function in Rats With Placental Ischemia-Induced Hypertension. Hypertension. 55:380-385.
Hagmann H, Thadhani R, Benzing T, Karu-manchi SA, Stepan H (2012). The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem. 58(5): 837-45. https://doi.org/10.1373/clinchem.2011.169094.
Herse F, Verlohren S, Wenzel K, Pape J, Muller DN, Modrow S, Wallukat G, Luft FC, et al. (2009). Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age?matched
case study. Hypertension. 53(2): 393-398. https://doi.org/10.1161/hypertensionaha.108.124115.
Holston A, Qian C, Yu KF, Epstein FH, Karumanchi SA, Levine RJ (2009). Circulating angiogenic factors in ges-tational proteinuria without hyperten-sion. Am J Obstet Gynecol. 200(4): 390
Karumanchi SA, Bdolah Y (2004). Hypoxia and sFlt-1 in Preeclampsia: The
Karumanchi A, Karumanchi SA, Lafayette R (2007). Pathophysiology of the cli-nical manifestations of preeclampsia. Clin J Am Soc Nephrol. 2(3): 543-549. https://doi.org/10.2215/cjn.03761106
Karumanchi A, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, et al. (2008). A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia. J Matern Fetal Neonatal Med. 21(1): 9-23. https://doi.org/10.1080/1476705-0701830480.
Levine R, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, et al. (2004). Circulating angiogenic factor and the risk of preeclampsia. N Engl J Med. 350(7): 672-683. https://doi.org/10.1056/nejmoa031884.
Levine R, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, et al. (2006). Soluble endoglin and other circulating antiangiogenic fac-tors in preeclampsia. N Engl J Med. 355(10): 992-1005. https://doi.org/-10.1056/nejmoa055352.
Li Z, Zhang Y, Ma JY, Kapoun AM, Shao Q, Kerr I, Lam A, et al. (2007). Recom-binant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension. 50(4): 686-692. https://doi.org/10.1-161/hypertensionaha.107.092098.
Poon LC, Nicolaides KH (2014). Early prediction of preeclampsia. Obstet Gynecol Int. 2014: 297397. https://dx.doi.org/10.1155%2F2014%2F297397.
Perkin E, et al. (2011). First trimester prediction of preeclampsia. Delfia Express PlGF Assay. 11:120
Shah DM (2007). Preeclampsia: new in-sight, Curr Opin Nephrol Hypertens. 16(3): 213-20. https://doi.org/10.10-97/mnh.0b013e3280d942e9.
Siddiqui A, Irani RA, Zhang Y, Dai Y, Blackwell SC, Ramin SM, Kellems RE, Xia Y (2011). Recombinant vasculer endothelial growth factor 121 attenueates autoantibody induced feature of preeclampsia in pregnant mice. Am J Hypertens. 24(5): 606-12. https://doi.org/10.1038/ajh.2010.247.
Sulistyowati S, Abadi A, Hood J, Soetjipto (2010). The influence of low HLA-G protein expression on HSP-70 and VCAM-1 profile in preeclampsia. Indones J Obstet Gynecol. 34(4): 185-190. http://inajog.com/index.php/journal/article/view/301/290.
Wang A, Rana S, Karumanchi SA (2009). Preeclampsia: The role of angiogenic factor in its pathogenesis. Am Physiol. 24: 147-15. https://doi.org/10.1152/physiol.00043.2008.
